SAVACassava Sciences, Inc.Healthcare · Biotechnologyas of 2026-08-13
Horizon

Issued 2026-08-13 at $1.03 · now $0.94 (2026-08-13, −9.0% since)

Based on its own history, a month from the 2026-08-13 close, SAVA has typically landed between $0.69 and $1.54 — a range of −33.5% to +49.2% from the issuance price $1.03.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,972 overlapping 1 month windows · 2006-09-262026-07-15 · basis climatology · forecast (batch). Probability up 53.8% (90% CI 51.656.0%, ≈1,400 obs).

The cone is anchored at the 2026-08-13 issuance close ($1.03) — the price the forecast resolves against on 2026-09-11, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where SAVA has typically landed a month from the 2026-08-13 close of $1.03 — the range is history, not a prediction.

$0.6853worst · -33.5%$1.54best · +49.2%
  • now $0.937 (-9.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $0.9855 (-4.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $0.8582$1.11
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $0.6853$1.54
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,972 windows spanning 2006-09-26 to 2026-08-13. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2018-05-30−79.4%−79.4%+2.8%
2018-05-31−79.0%−79.3%+3.5%
2018-06-15−78.6%−79.7%+0.0%
3 best
2020-12-31+1189.1%+0.0%+1189.1%
2021-01-04+797.0%+0.0%+1143.6%
2021-01-06+641.0%+0.0%+973.5%

4,972 overlapping windows · 2006-09-262026-08-13 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
60%
+16.9%
n=20
Feb
50%
+6.0%
n=20
Mar
40%
+1.0%
n=20
Apr
55%
+3.8%
n=20
May
40%
−1.6%
n=20
Jun
45%
−3.6%
n=20
Jul
55%
+1.2%
n=20
Aug
45%
+1.2%
n=20
Sep
63%
+18.8%
n=19
Oct
40%
−4.6%
n=20
Nov
65%
+2.9%
n=20
Dec
45%
+5.1%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-082025-07$5$12025-11-24: 1 insider purchase, $25K — Anderson Robert Eugene Jr2025-11-20: 1 insider purchase, $414K — Barry Richard2025-11-19: 1 insider purchase, $202K — Barry Richard2025-09-30: 1 insider purchase, $40K — Cook Robert Christopher2025-09-22: 1 insider purchase, $16K — Barry Richard2025-09-19: 2 insider purchases, $108K — Barry Richard …2025-09-18: 2 insider purchases, $426K — Barry Richard …2025-09: 6 open-market purchases, $591K2025-11: 3 open-market purchases, $641K↑ buys↓ salesdirector Anderson Robert Eugene Jr — Purchase on 2025-11-24, filed 1 day after the tradedirector Barry Richard — Purchase on 2025-11-20, filed 4 days after the tradedirector Barry Richard — Purchase on 2025-11-19, filed 1 day after the tradeofficer Cook Robert Christopher — Purchase on 2025-09-30, filed 2 days after the tradedirector Barry Richard — Purchase on 2025-09-22, filed 1 day after the tradedirector Barry Richard — Purchase on 2025-09-19, filed 3 days after the tradedirector Barry Richard — Purchase on 2025-09-19, filed 3 days after the tradedirector Barry Richard — Purchase on 2025-09-18, filed 4 days after the tradedirector Barry Richard — Purchase on 2025-09-18, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-11-24Anderson Robert Eugene JrdirectorPurchase8,600 @ $2.90$25Kownership Δ n/a−26.6%−60.0%8,600Form 4 · filed 1 day after the trade
2025-11-20Barry RicharddirectorPurchase150,000 @ $2.76$414K+19.0% of holding−14.8%−62.1%938,060Form 4 · filed 4 days after the trade
2025-11-19Barry RicharddirectorPurchase73,385 @ $2.75$202K+10.3% of holding−24.1%−65.5%788,060Form 4 · filed 1 day after the trade
2025-09-30Cook Robert ChristopherofficerPurchase13,725 @ $2.91$40Kownership Δ n/a+14.3%−39.8%13,725Form 4 · filed 2 days after the trade
2025-09-22Barry RicharddirectorPurchase7,172 @ $2.28$16K+1.0% of holding+70.9%−18.8%714,675Form 4 · filed 1 day after the trade
2025-09-19Barry RicharddirectorPurchase46,908 @ $2.29$107K+7.1% of holding+92.3%−16.9%707,503Form 4 · filed 3 days after the trade
2025-09-19Barry RicharddirectorPurchase400 @ $2.25$900+0.1% of holding+92.3%−16.9%660,595Form 4 · filed 3 days after the trade
2025-09-18Barry RicharddirectorPurchase185,233 @ $2.24$415K+39.0% of holding+87.2%−20.6%660,195Form 4 · filed 4 days after the trade
2025-09-18Barry RicharddirectorPurchase5,400 @ $2.13$12K+1.2% of holding+87.2%−20.6%474,962Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

11 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2025-10-21Bir Dawn CarterdirectorAward / grant53,00053,000Form 4
2025-05-23SCANNON PATRICK J MD PHDdirectorAward / grant26,50026,500Form 4
2025-05-23Anderson Robert Eugene JrdirectorAward / grant26,50026,500Form 4
2025-05-23GUSSIN ROBERT ZdirectorAward / grant26,50026,500Form 4
2025-05-23Gravier PierredirectorAward / grant26,50026,500Form 4
2025-05-23Nicaise ClaudedirectorAward / grant26,50026,500Form 4
2025-05-23O DONNELL MICHAEL JdirectorAward / grant26,50026,500Form 4
2025-04-17Barry RicharddirectorAward / grant350,000350,000Form 4
2025-04-17Nassif FredaofficerAward / grant100,000100,000Form 4
2025-04-17Schoen EricofficerAward / grant100,000100,000Form 4
2025-04-17Cook Robert ChristopherofficerAward / grant100,000100,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.